In both carcinoma components, there was moderate cytoplasmic p16 expression, but the fibroadenoma part did not show any cytoplasmic expression; however, nuclear p16 expression was strong in both carcinoma and fibroadenoma parts. The gene discussed is CDKN2A; the disease is Fibroadenoma.